[{"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017512"], "brand_name": ["DIANEAL LOW CALCIUM WITH DEXTROSE"], "generic_name": ["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"], "manufacturer_name": ["Vantive US Healthcare LLC"], "product_ndc": ["0941-0409", "0941-0411", "0941-0413", "0941-0415", "0941-0457", "0941-0459", "0941-0426", "0941-0427", "0941-0429", "0941-0424", "0941-0430", "0941-0433", "0941-0484", "0941-0487", "0941-0490"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "rxcui": ["799999", "800003", "800057", "800061", "800062", "800064", "800066", "800074", "800111", "800115", "800472", "800474"], "spl_id": ["36ea94f6-f614-9531-e063-6294a90aae55"], "spl_set_id": ["aa268d3f-7389-4f25-801f-5d4825495f08"], "package_ndc": ["0941-0411-05", "0941-0411-06", "0941-0411-07", "0941-0411-04", "0941-0411-11", "0941-0413-05", "0941-0413-06", "0941-0413-07", "0941-0413-01", "0941-0413-04", "0941-0415-05", "0941-0415-06", "0941-0415-04", "0941-0415-07", "0941-0415-01", "0941-0409-06", "0941-0409-05", "0941-0409-07", "0941-0409-01", "0941-0457-08", "0941-0457-02", "0941-0457-05", "0941-0457-01", "0941-0459-08", "0941-0459-02", "0941-0459-05", "0941-0459-01", "0941-0426-52", "0941-0426-53", "0941-0426-55", "0941-0427-52", "0941-0427-53", "0941-0427-55", "0941-0429-52", "0941-0429-53", "0941-0429-55", "0941-0424-51", "0941-0424-52", "0941-0424-53", "0941-0424-55", "0941-0430-51", "0941-0430-52", "0941-0430-53", "0941-0430-55", "0941-0433-51", "0941-0433-52", "0941-0433-53", "0941-0433-55", "0941-0484-01", "0941-0487-01", "0941-0490-01"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "94846", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide, Canada", "recall_number": "D-0587-2024", "product_description": "Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, For Intraperitoneal Administration Only, 6000 mL per bag, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.  NDC:  0941-0457-01", "product_quantity": "6,874 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.", "recall_initiation_date": "20240617", "center_classification_date": "20240706", "report_date": "20240717", "code_info": "Lot R24B25FA; Exp. 2/28/2026"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA215401"], "brand_name": ["XELSTRYM"], "generic_name": ["DEXTROAMPHETAMINE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-0205", "68968-0210", "68968-0215", "68968-0220"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["DEXTROAMPHETAMINE"], "spl_id": ["368e7b16-6dbd-4fe7-b2b1-732123f5fdf3"], "spl_set_id": ["0862f02a-72a8-41cc-8845-57cf4974bb6f"], "package_ndc": ["68968-0205-1", "68968-0205-3", "68968-0210-1", "68968-0210-3", "68968-0215-1", "68968-0215-3", "68968-0220-1", "68968-0220-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["TZ47U051FI"]}, "product_type": "Drugs", "event_id": "95701", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0055-2025", "product_description": "Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3", "product_quantity": "685 boxes", "reason_for_recall": "Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).", "recall_initiation_date": "20241031", "center_classification_date": "20241119", "report_date": "20241127", "code_info": "Lot # 95598, Exp 02/28/25"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["DRY EYE RELIEF"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0089"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED"], "rxcui": ["579907"], "spl_id": ["b2fd3f1c-69bb-4c0c-9a11-1c135377045c"], "spl_set_id": ["bd262028-32e9-052d-e053-2a95a90a5303"], "package_ndc": ["70000-0089-1"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0299-2024", "product_description": "Leader brand Dry Eye Relief (Carboxymethylcellulose Sodium 1%), packaged in 0.5 FL OZ (15 mL) bottles, Cardinal Health Dublin, Ohio 43017, NDC 70000-0089-1", "product_quantity": "23,208 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202494"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-6637", "0409-4916"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["727995", "792582"], "spl_id": ["f79ec8cb-b6a3-4ffb-bccf-d39f59d65621"], "spl_set_id": ["ea20a5eb-641e-48cd-bcfa-74c04c45dfda"], "package_ndc": ["0409-4916-24", "0409-4916-14", "0409-6637-24", "0409-6637-14"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "93681", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0234-2024", "product_description": "8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).", "product_quantity": "21200 Cartons", "reason_for_recall": "Presence of Particulate Matter; identified as glass", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot HA7295, EXP 03/01/2025"}, {"status": "Ongoing", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94550", "recalling_firm": "Revive Rx LLC dba Revive Rx Pharmacy", "address_1": "3831 Golf Dr Ste A", "address_2": "", "postal_code": "77018-5218", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0511-2024", "product_description": "Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64", "product_quantity": "751 vials", "reason_for_recall": "Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate", "recall_initiation_date": "20240420", "center_classification_date": "20240529", "report_date": "20240605", "code_info": "Lot #: 748127, Exp 9/24/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "94483", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0482-2024", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, (a) 90-count bottles (NDC 51991-747-90), (b) 1000-count bottles (NDC 51991-747-10), Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.", "product_quantity": "281,554/90 & 1000 count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240429", "center_classification_date": "20240504", "report_date": "20240515", "code_info": "220265: Exp. Feb 2025 220088: Exp. Nov 2024 220267: Exp. Feb 2025 220256: Exp. Feb 2025 220225: Exp. Jan 2025 220269: Exp. Feb 2025"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202687"], "brand_name": ["METHOXSALEN"], "generic_name": ["METHOXSALEN"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-752"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHOXSALEN"], "rxcui": ["1812434"], "spl_id": ["2af91a53-9d36-4415-b4f3-cd78b8ad36ad"], "spl_set_id": ["a6ec8292-9189-4ebd-862a-e1725eb29eef"], "package_ndc": ["64380-752-16"], "is_original_packager": [true], "nui": ["N0000010217", "N0000175984", "N0000009801", "N0000175879", "M0017973"], "pharm_class_moa": ["Photoabsorption [MoA]"], "pharm_class_epc": ["Photoactivated Radical Generator [EPC]", "Psoralen [EPC]"], "pharm_class_pe": ["Photosensitizing Activity [PE]"], "pharm_class_cs": ["Psoralens [CS]"], "unii": ["U4VJ29L7BQ"]}, "product_type": "Drugs", "event_id": "93703", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0260-2024", "product_description": "Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16", "product_quantity": "396 50-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20231229", "center_classification_date": "20240124", "termination_date": "20250701", "report_date": "20240131", "code_info": "Lot #: 7253092B, Exp Date 09/30/2025"}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0070-2025", "product_description": "JR WATKINS COOLING PAIN RELIEF PATCHES, Menthol 7.5%, 5 patches per box, Distributed By: J.R. Watkins, LLC, Oakland, CA 94612 UPC 8 56294 00878 5", "product_quantity": "10,368 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 56294 00878 5", "more_code_info": ""}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93702", "recalling_firm": "Haleon US Holdings LLC", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0316-2024", "product_description": "Robitussin Honey CF Max Non-Drowsy Adult (Acetaminophen 650mg, Dextromethorphan HBr 20 mg), a) 4 FL OZ (118mL) and b) 8 FL OZ (237 mL) bottles, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059", "product_quantity": "a) 31,632 bottles; b) 336,528 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20231226", "center_classification_date": "20240207", "report_date": "20240131", "code_info": "a) Lot#: T10810, Exp 10/31/2025 b) Lot#: T08730, T08731, T08732, T08733, Exp 05/31/2025; T10808, Exp 09/30/2025"}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0119-2025", "product_description": "Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) 1000-count bottles (NDC 0378-1823-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "118,324 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot #: a) 8165919, Exp. Date Dec 2024; 8172050, Exp. Date Mar 2025; 8183251, Exp. Date  Sept 2025 b) 3185542, Exp. date  Dec 2024; 3192838, Exp. Date Mar 2025; 3208172, Exp. Date Sept 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078352"], "brand_name": ["DESLORATADINE"], "generic_name": ["DESLORATADINE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DESLORATADINE"], "rxcui": ["349420"], "spl_id": ["511ec9ae-ec30-43cd-b408-4febb49716ac"], "spl_set_id": ["2a90b899-7746-43dc-ac8a-e754428eb30c"], "package_ndc": ["68180-153-01", "68180-153-03", "68180-153-06", "68180-153-02", "68180-153-11", "68180-153-12"], "is_original_packager": [true], "upc": ["0368180153016", "0368180153023"], "nui": ["N0000000190", "N0000175587"], "pharm_class_moa": ["Histamine H1 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-1 Receptor Antagonist [EPC]"], "unii": ["FVF865388R"]}, "product_type": "Drugs", "event_id": "93669", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0221-2024", "product_description": "Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.", "product_quantity": "100=29,184 bottles; 500=2922 bottles", "reason_for_recall": "CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.", "recall_initiation_date": "20231220", "center_classification_date": "20240109", "termination_date": "20250404", "report_date": "20240117", "code_info": "Lot #  G201822, exp. date Jan 2024, 100 count G201823, exp. date Jan 2024, 100 count G201824, exp. date Jan 2024, 500 count", "more_code_info": ""}, {"status": "Ongoing", "city": "Sacramento", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "95714", "recalling_firm": "Boulla LLC", "address_1": "2108 N ST #7929", "address_2": "", "postal_code": "95816", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0085-2025", "product_description": "ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.", "recall_initiation_date": "20241104", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot #: YZM240406, Exp: 04/05/2027", "more_code_info": ""}, {"status": "Completed", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M017"], "brand_name": ["AMERICAINE"], "generic_name": ["BENZOCAINE"], "manufacturer_name": ["Insight Pharmaceuticals LLC"], "product_ndc": ["63736-378"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOCAINE"], "rxcui": ["211315", "360349"], "spl_id": ["d727db6e-b2c9-4bf6-96c5-751713baaf6a"], "spl_set_id": ["4fd14452-0285-40c4-b835-36935c2056b2"], "package_ndc": ["63736-378-02"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5"], "upc": ["363736378820"]}, "product_type": "Drugs", "event_id": "93691", "recalling_firm": "Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0236-2024", "product_description": "Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 7", "product_quantity": "34,704 cans", "reason_for_recall": "Chemical Contamination: presence of benzene", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot # 1A16420, exp. date 01/31/2025"}, {"status": "Ongoing", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1800", "0378-1803", "0378-1805", "0378-1807", "0378-1809", "0378-1811", "0378-1813", "0378-1823", "0378-1815", "0378-1817", "0378-1819", "0378-1821"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["ca193039-55b1-4a7e-aa67-c4bff4f9f5b0"], "spl_set_id": ["e95720f2-91c9-a6d0-f7d5-8bcb94d07bbc"], "package_ndc": ["0378-1800-77", "0378-1800-10", "0378-1803-77", "0378-1803-10", "0378-1805-77", "0378-1805-10", "0378-1807-77", "0378-1807-10", "0378-1809-77", "0378-1809-10", "0378-1811-77", "0378-1811-10", "0378-1813-77", "0378-1813-10", "0378-1823-77", "0378-1823-10", "0378-1815-77", "0378-1815-10", "0378-1817-77", "0378-1817-10", "0378-1819-77", "0378-1819-10", "0378-1821-77"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95768", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Puerto Rico", "recall_number": "D-0126-2025", "product_description": "Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "43,765 bottles", "reason_for_recall": "Superpotent Drug and Subpotent Drug: potency failures obtained", "recall_initiation_date": "20241118", "center_classification_date": "20241212", "report_date": "20241218", "code_info": "Lot # a) 8180781, Exp. Date Aug 2025; b)3191628, Exp. Date Feb 2025; 3197139, Exp. Date Apr 2025; 3188976, Exp. Date Jan 2025; 3184929, Exp. Date Dec 2024; 3204909, Exp. Date Aug 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0529-2024", "product_description": "NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Roll-On NET WT 3 fl. oz. (88.7ml), Manufactured for Golden Tiger USA Albuquerque, NM, UPC 1 82294 00006 2", "product_quantity": "1,680", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 17323C3, Exp 06/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95511", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "N/A", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0025-2025", "product_description": "OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.", "product_quantity": "10845 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20241015", "center_classification_date": "20241024", "report_date": "20241030", "code_info": "Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["Meijer Distribution Inc"], "product_ndc": ["79481-0034"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["29f8fa4c-e1a4-3943-e063-6294a90a6b61"], "spl_set_id": ["f425a7aa-2503-2fe8-e053-2995a90ab352"], "package_ndc": ["79481-0034-9"], "is_original_packager": [true], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "94575", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0501-2024", "product_description": "Meijer Magnesium Citrate Saline Laxative Oral Solution Dye Free, Sugar Free Grape, 10 fl. oz bottle, Distributed by: Meijer Distribution Inc., Grand Rapids,MI 49544, NDC 79481-0034-9", "product_quantity": "24840", "reason_for_recall": "Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria", "recall_initiation_date": "20240501", "center_classification_date": "20240516", "report_date": "20240522", "code_info": "Lot #: A81834, Exp 1/31/2026"}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0015-2025", "product_description": "Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-024-58", "product_quantity": "1631 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000037046, exp. date 13-Oct-24", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065056"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2263", "0093-2264", "0093-4160", "0093-4155", "0093-4161", "0093-2267", "0093-2268", "0093-3107", "0093-3109"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308177", "308182", "308189", "308191", "308192", "308194", "313850", "598025"], "spl_id": ["31223839-1653-4906-826a-f9d6af179334"], "spl_set_id": ["4c0f348a-a65d-409c-8668-207c82a5e3cb"], "package_ndc": ["0093-2263-01", "0093-2264-01", "0093-4160-76", "0093-4160-78", "0093-4160-73", "0093-4155-79", "0093-4155-73", "0093-4155-80", "0093-4161-76", "0093-4161-78", "0093-4161-73", "0093-2267-01", "0093-2268-01", "0093-3107-01", "0093-3107-05", "0093-3109-53", "0093-3109-05"], "is_original_packager": [true], "upc": ["0300933107051", "0300932264014", "0300934161731", "0300933109055", "0300932267015", "0300932268012", "0300932263017", "0300934160734", "0300934155730"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0165-2024", "product_description": "AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.  NDC: 0093-4161-73", "product_quantity": "3 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 35447184A", "more_code_info": ""}, {"status": "Ongoing", "city": "Exton", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95190", "recalling_firm": "ProRx LLC", "address_1": "619 Jeffers Cir", "address_2": "", "postal_code": "19341-2540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0656-2024", "product_description": "TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only,  3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02", "product_quantity": "1,732 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240822", "center_classification_date": "20240905", "report_date": "20240911", "code_info": "Lot# ProRx052224, BUD 11/21/2024  ProRx061024, BUD 12/09/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0250-2024", "product_description": "Old Spice, PURE SPORT, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant & Deodorant Spray, Topical spray can, Net WT 6.0 OZ (170g), Distributed by Procter & Gamble, Cincinnati, OH 45202.  NDC: 37000-199-60, UPC 0 12044 00191 2", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204637"], "brand_name": ["AZELAIC ACID"], "generic_name": ["AZELAIC ACID"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-626"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["AZELAIC ACID"], "rxcui": ["1041518"], "spl_id": ["28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6"], "spl_set_id": ["0b5ab22e-c78a-4429-9a76-a4ba2d11fcde"], "package_ndc": ["68462-626-52"], "is_original_packager": [true], "upc": ["0368462626528"], "nui": ["N0000008841", "N0000009982"], "pharm_class_pe": ["Decreased Protein Synthesis [PE]", "Decreased Sebaceous Gland Activity [PE]"], "unii": ["F2VW3D43YT"]}, "product_type": "Drugs", "event_id": "95022", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0621-2024", "product_description": "Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa, 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52.", "product_quantity": "14,004 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240722", "center_classification_date": "20240729", "report_date": "20240807", "code_info": "Lot# 19241453; Exp MARCH 2026"}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0353-2024", "product_description": "CVS Health Lubricant Eye Ointment (Mineral oil 31.9%  Emollient, White petrolatum 57.7% Emollient), Packaged in in 3.5 gram tubes, Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895, NDC 76168-707-35, UPC 050428634141", "product_quantity": "159,334 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #:  A2F03, Exp. Date May-24;  A2I02, Exp. Date Aug-24; A2L02, Exp. Date Nov-24; A3C04, Exp. Date Feb-25; A3H04, Exp. Date Jul-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077091"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-320", "55111-321", "55111-322"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199245", "199246", "199247"], "spl_id": ["e3d50334-9896-b2f9-a481-8383eb84b16a"], "spl_set_id": ["07ad4366-4b21-f633-49f3-c2b35f88168d"], "package_ndc": ["55111-320-30", "55111-320-01", "55111-320-05", "55111-320-79", "55111-320-78", "55111-321-30", "55111-321-01", "55111-321-05", "55111-321-79", "55111-321-78", "55111-322-30", "55111-322-01", "55111-322-05", "55111-322-79", "55111-322-78"], "is_original_packager": [true], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "93833", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0312-2024", "product_description": "Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01", "product_quantity": "59,336 bottles", "reason_for_recall": "Misprint on tablet", "recall_initiation_date": "20240118", "center_classification_date": "20240206", "report_date": "20240214", "code_info": "Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0398-2024", "product_description": "fentaNYL 200 mcg/100 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Injection, (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0231-64, Bar Code 70004023164", "product_quantity": "613 Cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049754, Exp 01/12/24; 1223049992, Exp 01/23/24; 1223050066, Exp 01/25/24", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0414-2024", "product_description": "PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-12, Bar Code 70004081012", "product_quantity": "33,072 syringes; expanded 9,041 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223045536 Exp 12/06/23; 1223045710 Exp 12/10/23; 1223046574 Exp 01/12/24; 1223047579 Exp 02/21/24; 1223047764 Exp 03/06/24; 1223048363 Exp 03/30/24; 1223048364 Exp 03/30/24; 1223048566 Exp 04/06/24; 1223048573 Exp 04/07/24; 1223048574 Exp 04/07/24; 1223048643 Exp 04/11/24; 1223048697 Exp 04/12/24; 1223048742 Exp 04/13/24  Expanded lots#: 1223048065, Exp 04/06/2024; 1223048395, 1223048397, Exp 03/27/2024; 1223049980, Exp 06/05/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Wilmington", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA214679"], "brand_name": ["EPRONTIA"], "generic_name": ["TOPIRAMATE"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "product_ndc": ["52652-9001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOPIRAMATE"], "rxcui": ["2586427", "2586433"], "spl_id": ["30dc8c36-63cc-07b4-e063-6294a90a9abb"], "spl_set_id": ["e2a4df59-fead-4a01-9021-9eda02c48010"], "package_ndc": ["52652-9001-1", "52652-9001-2", "52652-9001-3"], "is_original_packager": [true], "nui": ["N0000008486", "N0000185506", "N0000182140"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["0H73WJJ391"]}, "product_type": "Drugs", "event_id": "93552", "recalling_firm": "Azurity Pharmaceuticals, Inc.", "address_1": "841 Woburn St", "address_2": "N/A", "postal_code": "01887-3414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0213-2024", "product_description": "Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1", "product_quantity": "2,220 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.", "recall_initiation_date": "20231208", "center_classification_date": "20240102", "termination_date": "20240424", "report_date": "20240110", "code_info": "Lot #: MB22020B, Exp 12/27/2023"}, {"status": "Ongoing", "city": "Dania Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94788", "recalling_firm": "Little Moon Essentials LLC", "address_1": "501 Old Griffin Rd", "address_2": "N/A", "postal_code": "33004-2774", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Ontario, Canada (2 retailers)", "recall_number": "D-0577-2024", "product_description": "Little Moon Essentials, Asana Kisser, (Camphor 1.35%, Menthol 2.86%), Packaged as a) 0.5 OZ (14G) metal tin, UPC Code 6 73673 88227 5, NDC 70722-216-05; b) 3 OZ (85-05G) metal tin UPC Code 6 73673 88216 9, NDC 70722-216-03; Little Moon Essentials LLC Dania Beach, Fl 33004", "product_quantity": "320 metal tins", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240620", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "lot code no expiration date on product:  a) 322230, 424040,  b) 322230, 325070, 324080, 325180, 325280, 328290, 426110, 423210, 426120, 422220, 423130, 428230, 325040"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE"], "manufacturer_name": ["CVS Pharmacy, Inc."], "product_ndc": ["51316-881"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["2a807f1b-9870-a9ea-e063-6394a90aed25"], "spl_set_id": ["fb808dc5-bf80-836c-e053-6294a90a80aa"], "package_ndc": ["51316-881-10"], "is_original_packager": [true], "upc": ["0050428346495"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "94575", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0500-2024", "product_description": "CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Cherry Flavor, 10 fl. oz bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, NDC 51316-881-10.", "product_quantity": "120830", "reason_for_recall": "Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria", "recall_initiation_date": "20240501", "center_classification_date": "20240516", "report_date": "20240522", "code_info": "Lot #: A81506, Exp 12/31/2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["NATURAL CHERRY HONEY HERB THROAT DROPS"], "generic_name": ["MENTHOL"], "manufacturer_name": ["Ricola Ag"], "product_ndc": ["54305-507"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MENTHOL"], "rxcui": ["1429019"], "spl_id": ["894d6e1c-e1f8-4967-8f83-e9d9b1e379cb"], "spl_set_id": ["229a7feb-c646-4557-85e5-0832682ab926"], "package_ndc": ["54305-507-10", "2000058693"], "is_original_packager": [true], "upc": ["0036602074507"], "unii": ["L7T10EIP3A"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0195-2024", "product_description": "Ricola CherryHoney Herb Throat Drops (menthol, 1.8 mg), 10 Drops per roll, Manufacturer: Ricola Ltd., 4242 Laufen, Switzerland; Distributed by: Ricola USA Inc., 6 Campus Drive, 2nd Floor South, Parsippany, NJ 07054.  NDC: 54305-507-10", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2000058693", "more_code_info": ""}, {"status": "Completed", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95125", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one distributor", "recall_number": "D-0633-2024", "product_description": "Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01", "product_quantity": "96 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.", "recall_initiation_date": "20240807", "center_classification_date": "20240813", "report_date": "20240821", "code_info": "Lot # AD12890, Exp 09/30/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95444", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0002-2025", "product_description": "Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.", "product_quantity": "11,568 tubes", "reason_for_recall": "Defective Container: Firm received complaints of broken tube at the seal.", "recall_initiation_date": "20240930", "center_classification_date": "20241002", "report_date": "20241009", "code_info": "Lot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026"}, {"status": "Ongoing", "city": "Verna", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA211711"], "brand_name": ["CLOBAZAM"], "generic_name": ["CLOBAZAM"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-315", "42571-316"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOBAZAM"], "rxcui": ["199450", "246172"], "spl_id": ["3afc2af9-3600-3648-e063-6394a90a7e51"], "spl_set_id": ["721dde68-db83-4dad-8649-8046cb455372"], "package_ndc": ["42571-315-30", "42571-315-90", "42571-315-05", "42571-315-32", "42571-315-11", "42571-315-20", "42571-315-91", "42571-315-01", "42571-316-30", "42571-316-90", "42571-316-32", "42571-316-11", "42571-316-20", "42571-316-91", "42571-316-01"], "is_original_packager": [true], "upc": ["0342571315016", "0342571316013"], "nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "unii": ["2MRO291B4U"]}, "product_type": "Drugs", "event_id": "93975", "recalling_firm": "Micro Labs Limited", "address_1": "Plot# S - 155", "address_2": "& N1 Phase Iii & Phase Iv; Verna Ind Estate Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0348-2024", "product_description": "Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01", "product_quantity": "24,768 bottles", "reason_for_recall": "CGMP Deviations: Out of specification for residual solvents.", "recall_initiation_date": "20240212", "center_classification_date": "20240222", "report_date": "20240228", "code_info": "ZOAG043"}, {"status": "Ongoing", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075903"], "brand_name": ["LISINOPRIL"], "generic_name": ["LISINOPRIL"], "manufacturer_name": ["Legacy Pharmaceutical Packaging, LLC"], "product_ndc": ["68645-608", "68645-609", "68645-610", "68645-611", "68645-612", "68645-613"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISINOPRIL"], "rxcui": ["197884", "205326", "311353", "311354", "314076", "314077"], "spl_id": ["32ffefa5-4b45-4094-e063-6294a90a8255"], "spl_set_id": ["f5db9549-e179-3db6-e053-2995a90a1544"], "package_ndc": ["68645-609-90", "68645-610-90", "68645-611-90", "68645-608-90", "68645-612-90", "68645-613-90"], "original_packager_product_ndc": ["31722-176", "31722-177", "31722-178", "31722-172", "31722-179", "31722-180"], "upc": ["0368645610900", "0368645609904", "0368645613901", "0368645611907", "0368645608907", "0368645612904"], "unii": ["E7199S1YWR"]}, "product_type": "Drugs", "event_id": "95749", "recalling_firm": "Evaric Pharmaceuticals Inc.", "address_1": "155 Commerce Dr", "address_2": "N/A", "postal_code": "11788-3925", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0061-2025", "product_description": "Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90.", "product_quantity": "222, 600 bottles", "reason_for_recall": "Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.", "recall_initiation_date": "20241115", "center_classification_date": "20241120", "report_date": "20241127", "code_info": "Lot #: 241103, exp. date 05/31/2026"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202289"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-050", "33342-051", "33342-052"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["cf31d31e-9355-47da-9c2b-8e4b84ac8159"], "spl_set_id": ["a04b5622-2c49-4d61-92b1-5dc523af7a24"], "package_ndc": ["33342-050-07", "33342-050-10", "33342-050-44", "33342-050-12", "33342-051-07", "33342-051-10", "33342-051-44", "33342-051-12", "33342-052-07", "33342-052-10", "33342-052-44", "33342-052-12"], "is_original_packager": [true], "upc": ["0333342051448", "0333342050106", "0333342052100", "0333342051103", "0333342052445", "0333342051073", "0333342052070"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "94592", "recalling_firm": "MACLEODS PHARMA USA, INC", "address_1": "103 College Rd E Fl 2", "address_2": "N/A", "postal_code": "08540-6611", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "USA Nationwide", "recall_number": "D-0498-2024", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44", "product_quantity": "1,048 bottles", "reason_for_recall": "Presence of foreign substance: plastic-like substance.", "recall_initiation_date": "20240507", "center_classification_date": "20240515", "report_date": "20240522", "code_info": "Lot #: BLK2304A, Exp. 07/31/2025"}, {"status": "Ongoing", "city": "Dania Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94788", "recalling_firm": "Little Moon Essentials LLC", "address_1": "501 Old Griffin Rd", "address_2": "N/A", "postal_code": "33004-2774", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Ontario, Canada (2 retailers)", "recall_number": "D-0574-2024", "product_description": "Little Moon Essentials, Dream Cream (Camphor 0.45%, Menthol 5%), Packaged as a) 2OZ (57G) glass jar, UPC Code 6 73673 88214 5, NDC 70722-232-02; b) 4OZ (113G) glass jar, UPC Code 6 73673 88804 8, NDC 70722-232-04; Little Moon Essentials LLC Dania Beach, Fl 33004", "product_quantity": "1264 glass jars", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240620", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "lot code no expiration dates on product: a) 328260, 321221, 425120, 427230,  b) 327150, 326260, 320270, 321301, 422020"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95897", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0108-2025", "product_description": "Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-459-30", "product_quantity": "50,304 bottles", "reason_for_recall": "CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.", "recall_initiation_date": "20241127", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "Lot#: 44378, 44597, 45804, Exp 12/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0293-2024", "product_description": "Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rugby Laboratories, Livonia, MI 48152, NDC 0536-1325-94", "product_quantity": "1,492,344 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0241-2024", "product_description": "Old Spice, SWEAT DEFENSE  ULTIMATE CAPTAIN, Aluminum Chlorohydrate 23.5%, Anti-Perspirant, Topical spray can 3.8 OZ (107 g), Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-385-10, UPC 0 37000 74947 9", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 03581458SA, Exp 11/30/2022;  10251458SU,   10261458SA, Exp 12/31/2022;"}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA021146"], "brand_name": ["ATROPINE SULFATE"], "generic_name": ["ATROPINE SULFATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1630", "0409-9630", "0409-4910", "0409-4911"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ATROPINE SULFATE"], "rxcui": ["1190546", "1190551", "1190552"], "spl_id": ["ab573c15-9504-48d1-bf4a-d8b8d7ae748a"], "spl_set_id": ["ad8916e7-206e-409e-2582-30d072845dd4"], "package_ndc": ["0409-1630-15", "0409-1630-10", "0409-9630-15", "0409-9630-05", "0409-4910-11", "0409-4910-34", "0409-4911-11", "0409-4911-34"], "is_original_packager": [true], "unii": ["03J5ZE7KA5"]}, "product_type": "Drugs", "event_id": "93681", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0235-2024", "product_description": "Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case).", "product_quantity": "24400 Cartons", "reason_for_recall": "Presence of Particulate Matter; identified as glass", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot GY2496, Exp 02/01/2025"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA215241"], "brand_name": ["MICAFUNGIN"], "generic_name": ["MICAFUNGIN"], "manufacturer_name": ["Northstar Rx LLC."], "product_ndc": ["16714-164", "16714-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["MICAFUNGIN SODIUM"], "rxcui": ["861379", "861383"], "spl_id": ["b96dcf3b-1308-4a44-9dcd-3dc35f9f5bf0"], "spl_set_id": ["9f4e9192-cb74-4018-90a2-69f9f21dd667"], "package_ndc": ["16714-164-01", "16714-164-10", "16714-301-01", "16714-301-10"], "is_original_packager": [true], "unii": ["IS1UP79R56"]}, "product_type": "Drugs", "event_id": "94922", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0596-2024", "product_description": "Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, NDC 16714-301-01 (vial), NDC 16714-301-10 (outer box).", "product_quantity": "n/a", "reason_for_recall": "Cross contamination with other products", "recall_initiation_date": "20240702", "center_classification_date": "20240710", "report_date": "20240717", "code_info": "Lot #: L300217, Exp. 04/31/2025."}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93935", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to three direct accounts in NM, AZ and UT.", "recall_number": "D-0372-2024", "product_description": "Infuvite Adult Multiple vitamins injection, single-dose vial 5mL, Rx only, MFG: Baxter Healthcare Corp., NDC 54643-5649-01", "product_quantity": "70 vials", "reason_for_recall": "cGMP Deviations: Products were stored outside the drug label specifications.", "recall_initiation_date": "20240207", "center_classification_date": "20240308", "termination_date": "20240814", "report_date": "20240320", "code_info": "519644"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94071", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0361-2024", "product_description": "Moxifloxacin PF, 1mg/ml, in Sterile Balanced Salt Solution (BSS) Sterile injection, Intracameral Use Only, Single- Dose Vial, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-096-42", "product_quantity": "40,090 vials", "reason_for_recall": "Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.", "recall_initiation_date": "20240220", "center_classification_date": "20240229", "report_date": "20240306", "code_info": "Lot #:2331147, Exp:6-Mar-24; 2331180, Exp: 21-Mar-24; 2331256, Exp: 2-Apr-24; 2331279, Exp: 3-Apr-24; 2331283, Exp: 7-Apr-24; 2331345, Exp: 20-Apr-24; 2331422, Exp: 27-Apr-24; 2331563, Exp: 29-May-24.", "more_code_info": ""}, {"status": "Terminated", "city": "Farnham", "state": "", "country": "United Kingdom", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95820", "recalling_firm": "Biocompatibles UK, Ltd.", "address_1": "Chapman House", "address_2": "Farnham Business Park; Weydon Lane", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0113-2025", "product_description": "Varithena (polidocanol injectable foam) Administration Pack, Contains: 3 silicone-free syringes, 2 compression pads, 1 Varithena Transfer Unit, 1 manometer tubing, Rx Only, Distributed by Biocompatibles Inc., a BTG International Group company. CN01114.3", "product_quantity": "432 administration packs", "reason_for_recall": "Defective Delivery System: incorrect silicone oil-free NormJect 10 mL Luer Lock Solo syringes packaged in the pack, instead of the required silicone oil-free NormJect 10 mL Luer Solo syringes (luer slip connection).", "recall_initiation_date": "20240815", "center_classification_date": "20241206", "termination_date": "20250221", "report_date": "20241218", "code_info": "Lot # 34067418, Exp. March 2026, 34067419, Exp. March 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "94483", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0483-2024", "product_description": "Duloxetine Delayed-Release Capsules, USP, 20 mg, , 500-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922, NDC 51991-746-05.", "product_quantity": "7,188/ 500 count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240429", "center_classification_date": "20240504", "report_date": "20240515", "code_info": "220456: Exp. Feb 2025"}, {"status": "Completed", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078518"], "brand_name": ["VALACYCLOVIR HYDROCHLORIDE"], "generic_name": ["VALACYCLOVIR"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-4275", "0378-4276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALACYCLOVIR HYDROCHLORIDE"], "rxcui": ["313564", "313565"], "spl_id": ["f0f10f6e-5e47-4a5b-a70b-578199d3f0f0"], "spl_set_id": ["56bf715d-8280-4557-9f98-9693932199e5"], "package_ndc": ["0378-4275-93", "0378-4275-77", "0378-4276-93", "0378-4276-77"], "is_original_packager": [true], "unii": ["G447S0T1VC"]}, "product_type": "Drugs", "event_id": "94482", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the united states", "recall_number": "D-0481-2024", "product_description": "Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-4275-77", "product_quantity": "143,230 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.", "recall_initiation_date": "20240425", "center_classification_date": "20240502", "report_date": "20240508", "code_info": "Lot #: 3183269, Exp. Date May 2025; 3157326, Exp. date June 2024", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93813", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0319-2024", "product_description": "Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01", "product_quantity": "858 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.", "recall_initiation_date": "20240115", "center_classification_date": "20240208", "termination_date": "20250131", "report_date": "20240214", "code_info": "Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95756", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0107-2025", "product_description": "Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceuticals, Inc., East Brunswick, NJ", "product_quantity": "233,003 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit", "recall_initiation_date": "20241119", "center_classification_date": "20241205", "report_date": "20241211", "code_info": "a) 30s; DT6023059A, DT6023060A, DT6023065A, DT6023069A, DT6023070A, exp. date Jan-25, DT6023080A, exp. date Feb-25, DT6023093A, exp. date Mar-25, DTC24012A, exp. date Dec-25;  b) 90s; DT6023108A, exp. date Apr-25, DTC23201A, exp. date Aug-25;  c) 1000s;  DT6022160A,  DT6022165A,  DT6022162A,  DT6022164A,  DT6022163A,  DT6022171A,  DT6022169A,  DT6022170A,  DT6022173A, exp. date Nov-24, DT6023009A,  DT6023007A,  DT6023008A,  DT6023011A,  DT6023034B, exp. date Dec-24, DT6023067C, exp. date Jan-25, DT6023114A, exp. date Apr-25, DTC23243A, exp. date Oct-25, DTC24040A, exp. date Dec-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93808", "recalling_firm": "Neptune Resources, LLC", "address_1": "1324 W 12th St Fl 5", "address_2": "N/A", "postal_code": "64101-1343", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0334-2024", "product_description": "Neptune's Fix, Tianeptine Extra Strength Elixir, 0.338 fl oz (10 mL) bottle, Distributed By Neptune Resources, LLC, 30 N. Gould Street, Ste R, Sheridan, WY 82801.", "product_quantity": "117,000 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.", "recall_initiation_date": "20240112", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "All lots"}, {"status": "Ongoing", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208845"], "brand_name": ["ZILRETTA"], "generic_name": ["TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION"], "manufacturer_name": ["Pacira Pharmaceuticals, Inc."], "product_ndc": ["65250-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR"], "rxcui": ["1947131", "1947133"], "spl_id": ["f5c73a99-9cc3-49f2-abaf-bbabfc33ba06"], "spl_set_id": ["cd5c4673-21f2-4126-9556-da847b3a228b"], "package_ndc": ["65250-003-01", "65250-001-01", "65250-002-01"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "94568", "recalling_firm": "PACIRA PHARMACEUTICALS INC", "address_1": "10578 Science Center Dr", "address_2": "N/A", "postal_code": "92121-1143", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0546-2024", "product_description": "Drug Vial Label: Zilretta\u00bf (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01.  Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01.  Carton Label: Drug Vial Label: Zilretta\u00bf (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01.", "product_quantity": "43,768 kits", "reason_for_recall": "Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.", "recall_initiation_date": "20240507", "center_classification_date": "20240607", "report_date": "20240619", "code_info": "Lot: 082657 (kit 23-9004), Exp: July 2024."}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95849", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA, OH, PR", "recall_number": "D-0099-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories  NDC 68001-413-06", "product_quantity": "37,916 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit", "recall_initiation_date": "20241114", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lots: DT2023001A, DT2023009A, exp date Jan 31, 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075682"], "brand_name": ["IBU"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-682", "55111-683", "55111-684"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807", "206905", "206913", "206917"], "spl_id": ["a7977972-4353-9ca0-d419-e37039010e7d"], "spl_set_id": ["24731405-219c-79b4-ecf0-7d5fbfda94ba"], "package_ndc": ["55111-682-09", "55111-682-01", "55111-682-05", "55111-683-30", "55111-683-50", "55111-683-09", "55111-683-01", "55111-683-05", "55111-684-30", "55111-684-50", "55111-684-60", "55111-684-09", "55111-684-01", "55111-684-05"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "95098", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0646-2024", "product_description": "IBU Ibuprofen Tablets, USP, 400 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a) NDC 55111-682-01 - 100 Tablets per bottle, b) NDC 55111-682-05 - 500 Tablets per bottle.", "product_quantity": "14940 bottles", "reason_for_recall": "Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.", "recall_initiation_date": "20240806", "center_classification_date": "20240826", "report_date": "20240904", "code_info": "a)NDC 55111-682-01 Lots C2207529, Exp 5/31/2026; C2210993, Exp 9/30/2026.  b)NDC 55111-682-05  Lots C2207530, Exp 5/31/2026; C2210992, C2210994, Exp 9/30/2026; C2213304, C2213305, Exp 11/30/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0307-2024", "product_description": "Lubricant Gel Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%), packaged in 0.33 FL OZ (10 mL) bottles, Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-4540-3", "product_quantity": "7,776 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95079", "recalling_firm": "EMPOWER CLINIC SERVICES LLC", "address_1": "7601 N Sam Houston Pkwy W Ste 100", "address_2": "", "postal_code": "77064-3595", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0630-2024", "product_description": "Empower Pharmacy, Estradiol Cypionate Injection, 10mg/mL, 5mL Sterile Multiple Dose Vial, For IM or SQ use only, RX only, Compounded by: Empower Pharmacy 7601 N Sam Houston Pkwy W Ste 100, Houston, TX 77064", "product_quantity": "2,797", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240802", "center_classification_date": "20240808", "termination_date": "20250328", "report_date": "20240814", "code_info": "Lot #: 179338, Beyond use date: 08/14/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Lompoc", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93831", "recalling_firm": "Den-Mat Holdings, LLC", "address_1": "1017 W Central Ave", "address_2": "", "postal_code": "93436-2701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0286-2024", "product_description": "OralProCare medicated lip treatment, Net Wt 9.9 g (0.35 oz) tube, Ethyl alcohol 6.0% Antibacterial, Manufactured by: Den-Mat Holdings, LLC, Lompoc, CA, 93436, USA, NDC 59883-500-01, UPC: 3 59883 00000 4.", "product_quantity": "344 tubes", "reason_for_recall": "CGMP Deviations: products may not conform to the labeled specifications.", "recall_initiation_date": "20240116", "center_classification_date": "20240131", "report_date": "20240207", "code_info": "Lot #s: 2319500023, Exp: 01- 12-2024; 2330400002, Exp: 11-02-2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090509"], "brand_name": ["TACROLIMUS"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-525", "55111-526", "55111-527"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["198377", "198378", "313190"], "spl_id": ["706bafff-d629-291c-5ce5-83d74a638860"], "spl_set_id": ["61dee012-43af-0e9a-3843-9b9b91e022c4"], "package_ndc": ["55111-525-30", "55111-525-01", "55111-525-05", "55111-525-79", "55111-525-78", "55111-526-30", "55111-526-01", "55111-526-05", "55111-526-79", "55111-526-78", "55111-527-30", "55111-527-01", "55111-527-05", "55111-527-79", "55111-527-78"], "is_original_packager": [true], "upc": ["0355111527015", "0355111525011", "0355111526018"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "93622", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0219-2024", "product_description": "Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01", "product_quantity": "8,280 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.", "recall_initiation_date": "20231215", "center_classification_date": "20240105", "termination_date": "20240916", "report_date": "20240117", "code_info": "Lot# C2307275; Exp.  January 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94838", "recalling_firm": "GLOBAL WIDGET LLC", "address_1": "8419 Sunstate St", "address_2": "", "postal_code": "33634-1306", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0614-2024", "product_description": "Nature's Script CBD Cryotherapy Pain Relief Roll on (menthol 4%) 200mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, UPC code: 8-40078-56731-5", "product_quantity": "2466 bottles", "reason_for_recall": "Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.", "recall_initiation_date": "20240625", "center_classification_date": "20240722", "report_date": "20240731", "code_info": "Lot #: 230346, Exp. date Aug 2025; 230090 Exp. date Feb 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0401-2024", "product_description": "fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095,  NDC 70004-0251-64, Bar Code 70004025164", "product_quantity": "130 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048722, Exp 11/29/23; 1223049096, Exp 12/15/23", "more_code_info": ""}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94648", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to CA, FL, OK, KS and CT", "recall_number": "D-0505-2024", "product_description": "Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03", "product_quantity": "66 bottles of 30 tablets", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240510", "center_classification_date": "20240521", "report_date": "20240529", "code_info": "Lot #: J2022G, Exp: 01/01/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0527-2024", "product_description": "NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Tube 4 oz (113.39 g), Mfr. for Golden Tiger USA Albuq, NM, UPC 1 82294 00002 4", "product_quantity": "3,000", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 01623C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202868"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-357"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312504"], "spl_id": ["b0251572-aa7f-434a-a7ff-33ccbc37dfaf"], "spl_set_id": ["5b054142-7372-4641-be27-dca630a97ad9"], "package_ndc": ["68462-357-90", "68462-357-01", "68462-357-05"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "94715", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0604-2024", "product_description": "Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-01", "product_quantity": "285,840 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240530", "center_classification_date": "20240717", "report_date": "20240724", "code_info": "Lot#:  17221446, 17221445, Exp May-31-24; 17221393, 17221403, 17221405, 17221503, 17221508, Exp Jun-30-24; 17221567, 17221566, 17221719, 17221731, Exp Jul-31-24; 17221891, 17221892, 17221900, 17221992, 17222022, Exp Aug-31-24; 17222056, 17222043, 17222068, 17222079, 17222099, 17222103, 17222114, 17222119, 17222188, 17222199, 17222209, 17222200, Exp Sep-30-24; 17222265, 17222269, Exp Oct-31-24; 17222527, 17222530, 17222583, 17222586, 17230051, 17230075, 17230067, Exp Nov-30-24;", "more_code_info": ""}, {"status": "Terminated", "city": "Sarasota", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93847", "recalling_firm": "OMEZA LLC", "address_1": "1610 Northgate Blvd", "address_2": "", "postal_code": "34234-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US Nationwide", "recall_number": "D-0288-2024", "product_description": "Omeza Lidocaine Lavage pain relief oil 10*2mL VIALS", "product_quantity": "4390 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240119", "center_classification_date": "20240204", "termination_date": "20241017", "report_date": "20240214", "code_info": "Lots:  28622 2-1, Exp. 04/24/2024 286222-3, Exp. 1/25/2024 or 04/25/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Libertyville", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M013"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["A-S Medication Solutions"], "product_ndc": ["50090-5313"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["198440"], "spl_id": ["91673a66-2b9e-47ee-bb4b-61ec914a6226"], "spl_set_id": ["061c91d5-5aa8-4556-a344-197b7e8a10b8"], "package_ndc": ["50090-5313-1", "50090-5313-2", "50090-5313-3", "50090-5313-4", "50090-5313-5"], "original_packager_product_ndc": ["0904-6730"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "94873", "recalling_firm": "A-S Medication Solutions LLC", "address_1": "2401 Commerce Dr", "address_2": "", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-0631-2024", "product_description": "Acetaminophen Extra Strength Tablets, 500 mg each, 100 count bottles, Packaged By: A-S Medication Solutions, Libertyville, IL 60048. NDC: 50090-5313-2", "product_quantity": "429 bottles", "reason_for_recall": "Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.", "recall_initiation_date": "20240621", "center_classification_date": "20240808", "termination_date": "20250507", "report_date": "20240814", "code_info": "Lot: 4138197; Exp 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217455"], "brand_name": ["REGADENOSON"], "generic_name": ["REGADENOSON"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-364"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["REGADENOSON"], "spl_id": ["9f2129bf-2527-42da-b07a-f20cac3246de"], "spl_set_id": ["a81d66a7-b714-439e-ad7b-c7caf9d6f3b8"], "package_ndc": ["36000-364-01"], "is_original_packager": [true], "upc": ["0336000364010"], "nui": ["N0000178375", "N0000175788"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "unii": ["2XLN4Y044H"]}, "product_type": "Drugs", "event_id": "95664", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0039-2025", "product_description": "Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015.  NDC: 36000-364-01", "product_quantity": "60,594 units", "reason_for_recall": "Labeling: Missing Label", "recall_initiation_date": "20241030", "center_classification_date": "20241106", "report_date": "20241113", "code_info": "Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0455-2024", "product_description": "SILVERBACK XXX POWER MALE ENHANCEMENT, 2 fl. oz., UPC 8 700470 032762", "product_quantity": "7 pieces", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0354-2024", "product_description": "Lubricant PM Ointment (Mineral Oil 42.5% and White Petrolatum 57.3%), Packaged in 3.5 gram tubes, Distributed by: AACE Pharmaceuticals, Inc., Fairfield, NJ 07004, NDC 71406-124-35, UPC 371406124356", "product_quantity": "355,120 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #: A2G01, A2G02, Exp. Date Jun-24; A3F08, A3F09, Exp. Date May-25; A3J17, A3J18, Exp. Date Sep-25", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0405-2024", "product_description": "HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = 0.2 mg/ml) 30 mL fill 35 mL Plungerless Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-16, Bar Code 70004030016", "product_quantity": "5,734 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048530, Exp 11/22/23; 1223048692 Exp 11/29/23; 1223048739 EXP  11/30/23; 1223048826 Exp 12/05/23; 1223048963 Exp 12/08/23; 1223048964 EXP  12/11/23; 1223049111 Exp 12/15/23; 1223049128 Exp12/19/23; 1223049210 EXP  12/21/23; 1223049234 Exp 12/22/23; 1223049257 Exp 12/22/23; 1223049322 Exp 12/27/23; 1223049416 Exp 12/28/23; 1223049528 Exp 01/03/24; 1223049559 Exp 01/04/24; 1223049614 Exp 01/05/24; 1223049632 Exp 01/08/24; 1223049725 Exp 01/11/24; 1223049792 Exp 01/15/24; 1223049793 Exp 01/15/24; 1223049905 Exp 01/19/24; 1223050029 Exp 1/24/24; 1223050061 Exp 01/25/24; 1223050179 Exp 01/29/24", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202496"], "brand_name": ["IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE"], "generic_name": ["IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-840"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE", "IPRATROPIUM BROMIDE"], "rxcui": ["1437702"], "spl_id": ["14b7dfcc-b3a8-4027-9544-8d52ec2aacf3"], "spl_set_id": ["89d59bd9-c826-413c-8ed9-a1521a0c7cc5"], "package_ndc": ["69097-840-34", "69097-840-53", "69097-840-87", "69097-840-64"], "is_original_packager": [true], "unii": ["021SEF3731", "J697UZ2A9J"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0161-2024", "product_description": "Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials (2 pouches of 30 - 3 mL vials each), Manufactured By: The Ritedose Corporation, Columbia, SC 29203; Distributed By: Cipla USA Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-840-64", "product_quantity": "2 cartons", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 21C56", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211892"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-440", "16729-441", "16729-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["40aa0834-3fd8-c230-e063-6294a90a800d"], "spl_set_id": ["6bad4e06-c0a1-4123-83c2-67d3b081e8a9"], "package_ndc": ["16729-440-10", "16729-440-15", "16729-440-01", "16729-441-10", "16729-441-15", "16729-441-01", "16729-442-10", "16729-442-15", "16729-442-01"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95501", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0031-2025", "product_description": "Cinacalcet Tablets, 60 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-441-10, b) 90 Tablets per bottle, NDC: 16729-441-15, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.", "recall_initiation_date": "20241010", "center_classification_date": "20241031", "report_date": "20241106", "code_info": "a) Lot #:              Expiry Date: M2204481              02/2025 M2212389              08/2025 M2214271              09/2025 M2215970              10/2025 M2216458              10/2025  b) Lot #:             Expiry Date: M2212869           08/2025 M2216362           09/2025 M2215969           10/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0240-2024", "product_description": "Old Spice, SWEAT DEFENSE PURE SPORT PLUS, Dry Spray,  (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g) cans,  Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-387-10, UPC 0 37000 72974 7", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 12081458SB, Exp 6/30/2021; 92181458FA, Exp 7/31/21;"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA085082"], "brand_name": ["DICYCLOMINE HYDROCHLORIDE"], "generic_name": ["DICYCLOMINE HYDROCHLORIDE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0794", "0591-0795"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DICYCLOMINE HYDROCHLORIDE"], "rxcui": ["991061", "991086"], "spl_id": ["cdc9e5f4-36d9-40dc-894f-2d8682e4a61b"], "spl_set_id": ["a5937c7b-cdfc-46e6-a0fa-541b24f91d47"], "package_ndc": ["0591-0794-01", "0591-0794-10", "0591-0795-01", "0591-0795-10"], "is_original_packager": [true], "upc": ["0305910795016", "0305910794019"], "unii": ["CQ903KQA31"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0175-2024", "product_description": "Dicyclomine Hydrochloride Tablets, USP 20 mg, 100 Tablets, Rx only, Manufactured For: Teva Pharmaceuticals USA, Parsippany, NJ 07054.  NDC: 0591-0795-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 3197790", "more_code_info": ""}, {"status": "Terminated", "city": "Pittsburgh", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93880", "recalling_firm": "Alpha Aromatics", "address_1": "294 Alpha Dr", "address_2": "N/A", "postal_code": "15238-2906", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two accounts in NC and MI", "recall_number": "D-0338-2024", "product_description": "Pure Care Foaming Mint Hand Sanitizer 62%, Distributed by: Air Scent International, 290 Alpha Drive, RIDC Industrial Park, Pittsburg, PA 15238 USA, www.airscent.com, NDC 75009-562.", "product_quantity": "676 gallons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240125", "center_classification_date": "20240216", "termination_date": "20240814", "report_date": "20240228", "code_info": "Lot # 2022-012884 Lot # 2023-002020 Lot # 2023-003532 Lot # 2023-003761"}, {"status": "Ongoing", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021067"], "brand_name": ["ASMANEX"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Organon LLC"], "product_ndc": ["78206-114", "78206-115"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["746803", "746804", "746810", "746811", "746812", "746813", "746814", "746815", "790283", "790284"], "spl_id": ["4742e310-f27e-4c57-97d2-29034ed8bea8"], "spl_set_id": ["10b36fb2-6b0d-4f20-b197-3564d6f594b9"], "package_ndc": ["78206-114-03", "78206-114-04", "78206-114-02", "78206-114-01", "78206-114-59", "78206-115-59", "78206-115-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "94703", "recalling_firm": "Organon Llc", "address_1": "30 Hudson St Fl 33", "address_2": "N/A", "postal_code": "07302-4804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0551-2024", "product_description": "Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-03", "product_quantity": "2,551 units", "reason_for_recall": "Defective Container", "recall_initiation_date": "20240528", "center_classification_date": "20240610", "report_date": "20240619", "code_info": "Lot #: X024051, Exp 04/25/2025"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94900", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0601-2024", "product_description": "Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02.", "product_quantity": "116,144 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.", "recall_initiation_date": "20240628", "center_classification_date": "20240716", "report_date": "20240724", "code_info": "Lot #s: CNSDH, Exp. 6/30/2024; CNWVM, CNWWH, Exp. 07/31/2024; CNXKW, CNXKY, CNXMB, CNXMH, Exp. 09/30/2024; CPBTP, CPBTV, Exp. 11/30/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Lilburn", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94893", "recalling_firm": "Guru Inc.", "address_1": "4370 Lawrenceville Hwy NW", "address_2": "# 2204", "postal_code": "30047-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Retail: South Carolina, North Carolina, Ohio;  Consumer level: Nationwide within USA", "recall_number": "D-0666-2024", "product_description": "Infla-650 Herbal Dietary Supplement, 700mg,  packaged in pouches containing 60 capsules, Distributed by: Guru Inc., 4370 Lawrenceville Hwy NW, P.O. Box 2204, Lilburn, GA 30047-1100, USA. Ph.: 872 216 1566, http://www.dalayurevda.com, Made in India, UPC: 042535355019", "product_quantity": "", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.", "recall_initiation_date": "20240626", "center_classification_date": "20240923", "report_date": "20241002", "code_info": "Batch # IN-032, Exp 11/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M013"], "brand_name": ["MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK"], "generic_name": ["DEXTROMETHORPHAN HBR, GUAIFENESIN, ACETAMINOPHEN, DOXYLAMINE SUCCINATE"], "manufacturer_name": ["Genexa Inc."], "product_ndc": ["69676-0079"], "product_type": ["HUMAN OTC DRUG"], "rxcui": ["2692302", "2692303", "2692304"], "spl_id": ["38f8afad-542e-ae0c-e063-6294a90a243f"], "spl_set_id": ["18835205-a9e3-15c2-e063-6394a90a8107"], "package_ndc": ["69676-0079-3", "69676-0077-9", "69676-0094-9", "8500157361"], "is_original_packager": [true], "upc": ["850015736155"]}, "product_type": "Drugs", "event_id": "95430", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "N/A", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two accounts that may have distributed the product further to the Retail Level.", "recall_number": "D-0033-2025", "product_description": "Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP  400mg),  packaged in 4 oz bottles further package in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code # 850015736155", "product_quantity": "72,648 bottles", "reason_for_recall": "Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.", "recall_initiation_date": "20240925", "center_classification_date": "20241101", "report_date": "20241113", "code_info": "Lot# 0104V, Exp 07/2025; 0106V, Exp 09/2024", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205467"], "brand_name": ["FEBUXOSTAT"], "generic_name": ["FEBUXOSTAT"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-721", "47335-722"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FEBUXOSTAT"], "rxcui": ["834235", "834241"], "spl_id": ["53dfe063-e9bf-4069-b4cc-5a83a27d18ec"], "spl_set_id": ["1f7541bd-bf32-422b-b99a-89193cf193ca"], "package_ndc": ["47335-721-83", "47335-721-81", "47335-721-13", "47335-722-83", "47335-722-88", "47335-722-18"], "is_original_packager": [true], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["101V0R1N2E"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0264-2024", "product_description": "Febuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 47335-721-83.", "product_quantity": "55,272 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s: DNE0866B Exp. 06/30/2025, DNE1045A, DNE1046B Exp. 08/31/2025"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208368"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "product_ndc": ["43598-367", "43598-368", "43598-369"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["b6dbd55a-a71d-0cf8-2c73-7ebbfc032906"], "spl_set_id": ["0837aabc-e796-0e07-8958-71f1ff6e89bf"], "package_ndc": ["43598-367-30", "43598-367-05", "43598-368-30", "43598-368-05", "43598-369-30", "43598-369-05"], "is_original_packager": [true], "upc": ["0343598369303"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95500", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0027-2025", "product_description": "Cinacalcet Tablets, 60 mg, 30-count bottles, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India, NDC 43598-368-30.", "product_quantity": "35880 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241009", "center_classification_date": "20241028", "report_date": "20241106", "code_info": "Lot# T2200698, Exp 01/2025; T2201444, Exp 03/2025; T2202827, Exp 06/2025; T2300531, Exp 12/2025; T2301696, Exp 02/2026; T2304726, Exp 08/2026; T2400480, Exp 11/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0456-2024", "product_description": "The GOAT SUBLINGUAL STRIP, MALE ENHANCEMENT, 2 Pack, Distributed by Hombres LLC, 130 Maccormick Ave, Suite 105, Costa Mesa, A, UPC 6 61631 26363 1.", "product_quantity": "10 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0023-2025", "product_description": "Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-079-56", "product_quantity": "1008 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000037436, exp. date 30-Oct-24 C274-000038893, exp. date 7-Jan-25", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0425-2024", "product_description": "VANCOMYCIN 1.25 g added to 0.9% Sodium Chloride 250 mL Injection, 250 mL bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0923-59, Bar Code 70004092359", "product_quantity": "368 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049049 Exp 12/28/23", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA021859"], "brand_name": ["HYLENEX RECOMBINANT"], "generic_name": ["HYALURONIDASE"], "manufacturer_name": ["Antares Pharma, Inc."], "product_ndc": ["18657-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["HYALURONIDASE (HUMAN RECOMBINANT)"], "rxcui": ["630936", "630939"], "spl_id": ["37c02d08-e964-4065-ba96-69fe8eed5c2e"], "spl_set_id": ["3023cc56-ed4b-4e87-b3a1-81b20943f658"], "package_ndc": ["18657-117-01", "18657-117-02", "18657-117-04", "1000008319", "1000008206", "1000008205"], "is_original_packager": [true], "nui": ["N0000175531", "M0009499"], "pharm_class_epc": ["Endoglycosidase [EPC]"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "unii": ["743QUY4VD8"]}, "product_type": "Drugs", "event_id": "95830", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Virgina", "recall_number": "D-0116-2025", "product_description": "Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ  NDC 18657-117-04", "product_quantity": "5 cartons/20 units each carton", "reason_for_recall": "cGMP Deviations: Temperature excursion", "recall_initiation_date": "20240911", "center_classification_date": "20241210", "termination_date": "20250820", "report_date": "20241218", "code_info": "Serial # 100000831961 100000820688 100000820689 100000820515", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077929"], "brand_name": ["MELOXICAM"], "generic_name": ["MELOXICAM"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-158", "69097-159"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MELOXICAM"], "rxcui": ["152695", "311486"], "spl_id": ["2c9a4c52-7394-432a-9e50-b51c8a90972e"], "spl_set_id": ["bb83cd61-0a82-4fe0-b72e-5b715cbd656d"], "package_ndc": ["69097-158-15", "69097-158-07", "69097-158-12", "69097-159-12", "69097-159-07", "69097-159-15"], "is_original_packager": [true], "upc": ["0369097159078", "0369097158071"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["VG2QF83CGL"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0190-2024", "product_description": "Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156.  NDC: 69097-159-15", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch KA11489", "more_code_info": ""}, {"status": "Terminated", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M002"], "brand_name": ["LITTLE REMEDIES"], "generic_name": ["SIMTHICONE"], "manufacturer_name": ["Medtech Products Inc."], "product_ndc": ["63029-103"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DIMETHICONE"], "rxcui": ["198857"], "spl_id": ["efeb43e2-a60e-4f51-81e5-f8c0db1f75be"], "spl_set_id": ["874d3f1d-1e4a-49ab-8285-4d6bf2601d5e"], "package_ndc": ["63029-103-01", "63029-103-02"], "is_original_packager": [true], "nui": ["N0000010282"], "pharm_class_pe": ["Skin Barrier Activity [PE]"], "unii": ["92RU3N3Y1O"]}, "product_type": "Drugs", "event_id": "94712", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "N/A", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Recalled units were distributed to one customer. 100% recovered (113,544 units) and controlled at Denison Pharmaceuticals.", "recall_number": "D-0557-2024", "product_description": "Little Remedies Gas Relief Drops (Simethicone/Antigas), packaged in 1 fl. oz. (30 mL) bottle with dropper, Dist by Medtech Products Inc., Tarrytown, NY 10591, NDC 63029-103-02", "product_quantity": "113,544 bottles", "reason_for_recall": "cGMP deviations: Test results confirmed aypical Burkholderia Cepacia were a result of personnel error.", "recall_initiation_date": "20240528", "center_classification_date": "20240617", "termination_date": "20250826", "report_date": "20240626", "code_info": "Lot #: 0855, Exp. 8/31/ 2025"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0381-2024", "product_description": "TRP Natural Eyes Aging Eye Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-027-15.", "product_quantity": "19,344 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: G806, Exp: 06-01-2025, G807, Exp: 10-27-2026."}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0379-2024", "product_description": "TRP Eye strain Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-172-15.", "product_quantity": "10,536 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: E206, Exp: 09-21-2025"}, {"status": "Completed", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93869", "recalling_firm": "Bestco LLC", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0331-2024", "product_description": "Family Wellness Cherry Cough Drops Menthol cough suppressant/Oral Anesthetic, 80 drops per bag, item number 20001187, Bestco, 288 Mazeppa Road, Mooresville, NC 28115", "product_quantity": "46 cases/6 pack each", "reason_for_recall": "CGMP Deviations: Potential Glass and Silicone particulates in product", "recall_initiation_date": "20240119", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "100042290, Exp 12/31/2026"}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95146", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0636-2024", "product_description": "Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.", "product_quantity": "", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240815", "center_classification_date": "20240816", "report_date": "20240828", "code_info": "Lot#: C274-000037397, C274-000037398, C274-000037399, C274-000037400, Exp. Date 10/14/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0243-2024", "product_description": "Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Waterlily, Topical Spray Can, Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-381-10; UPC 0 37000 72372 1; 12/pack UPC 0 37000 72991 4", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 92191458FB, Exp 7/31/2021; 00091458SA, Exp 12/31/2021; 00091458SA, 11821458SB, Exp 6/30/2023."}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206128"], "brand_name": ["METHOCARBAMOL"], "generic_name": ["METHOCARBAMOL"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-223"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METHOCARBAMOL"], "rxcui": ["238175"], "spl_id": ["980dbd07-e6d0-4d8a-8cbe-37c36c9e94c5"], "spl_set_id": ["e8e8da30-64cf-42ea-bf71-d085b0be8a09"], "package_ndc": ["55150-223-10"], "is_original_packager": [true], "nui": ["N0000175730", "N0000175737"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "unii": ["125OD7737X"]}, "product_type": "Drugs", "event_id": "94025", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0440-2024", "product_description": "Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10", "product_quantity": "1,552  10ml x 25/carton", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20240215", "center_classification_date": "20240408", "report_date": "20240417", "code_info": "Lot #: 3MC23011, Exp 11/30/2026"}, {"status": "Ongoing", "city": "Dania Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94788", "recalling_firm": "Little Moon Essentials LLC", "address_1": "501 Old Griffin Rd", "address_2": "N/A", "postal_code": "33004-2774", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Ontario, Canada (2 retailers)", "recall_number": "D-0571-2024", "product_description": "Little Moon Essentials, Magical Muscle Oil, (Camphor 1.95%, Menthol 3.75%) packaged as: a) 2 FL OZ (59ML) glass jar, UPC Code 6 73673 88202 2, NDC 70722-246-02; b) 4 FL OZ (118ML) jar, UPC Code 6 73673 88233 6, NDC 70722-246-04;  Little Moon Essentials LLC Dania Beach, Fl 33004", "product_quantity": "1654 glass jars", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240620", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "lot code No expiration date on product:  a) 325240, 320260, 329011, 324021, 328221, 421110, 422120, 423120, 421220, 426220, 428220,  b) 329230, 328140, 320290, 328011."}, {"status": "Completed", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94519", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0603-2024", "product_description": "Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10", "product_quantity": "3,694 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240430", "center_classification_date": "20240716", "report_date": "20240724", "code_info": "Lot#: 8147041; Exp. June 2024 Lot#: 8163765; Exp. March 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "94990", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0632-2024", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, [NDC 64980-514-05].", "product_quantity": "362,544 bottles", "reason_for_recall": "Defective container; yellow colored spike from cap lodged in the nozzle", "recall_initiation_date": "20240718", "center_classification_date": "20240813", "report_date": "20240821", "code_info": "Lot Number: 083J022, Expiration Date: September- 25; 083L046, Expiration date: November- 25; 083H009, Expiration date: July- 25", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0092-2025", "product_description": "Compliance Dishwashing Liquid & Antibacterial Soap, PCMX 0.1%, Net Contents: 1 Gallon, 128 Ounces, 3.785 Liters,  Royal Corporation, 10232 Palm Drive, Santa Fe Springs, CA 90670", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210742"], "brand_name": ["CHLORTHALIDONE"], "generic_name": ["CHLORTHALIDONE"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc."], "product_ndc": ["43598-719", "43598-720"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORTHALIDONE"], "rxcui": ["197499", "197500"], "spl_id": ["46902081-6a2d-4489-b828-351a33d405b5"], "spl_set_id": ["9e9e9ced-6960-4d2f-bb23-ef8b2435da75"], "package_ndc": ["43598-719-01", "43598-719-10", "43598-720-01", "43598-720-10"], "is_original_packager": [true], "upc": ["0343598720012"], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0172-2024", "product_description": "CHLORTHALIDONE Tablets, USP,  25MG, 1000 Tablets, Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854 USA; Manufactured For: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA. NDC:  43598-719-10", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2107329UM", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA008372"], "brand_name": ["ACTHAR"], "generic_name": ["REPOSITORY CORTICOTROPIN"], "manufacturer_name": ["Mallinckrodt ARD LLC"], "product_ndc": ["63004-8710", "63004-8712", "63004-8711"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "SUBCUTANEOUS"], "substance_name": ["CORTICOTROPIN"], "rxcui": ["309541", "1040025", "2685293", "2685296", "2685298", "2685299"], "spl_id": ["2f3a449b-3b11-4e73-bb44-621c167a0934"], "spl_set_id": ["7b48ddec-e815-45f4-9ca0-5c0daaf56f30"], "package_ndc": ["63004-8710-1", "63004-8710-2", "63004-8712-1", "63004-8712-4", "63004-8711-1", "63004-8711-4"], "is_original_packager": [true], "upc": ["0363004871213"], "nui": ["M0000499", "N0000175941"], "pharm_class_cs": ["Adrenocorticotropic Hormone [CS]"], "pharm_class_epc": ["Adrenocorticotropic Hormone [EPC]"], "unii": ["K0U68Q2TXA"]}, "product_type": "Drugs", "event_id": "93945", "recalling_firm": "Mallinckrodt Hospital Products Inc.", "address_1": "440 Us Highway 22", "address_2": "Ste 302", "postal_code": "08807-2477", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0340-2024", "product_description": "Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1", "product_quantity": "8 vials involved in recall (16,479 vials distributed)", "reason_for_recall": "cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.", "recall_initiation_date": "20240206", "center_classification_date": "20240221", "report_date": "20240228", "code_info": "Lot #: 1564-103, Exp 9/30/2024"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0093-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-850-01.", "product_quantity": "34848 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #s: 17222544, Exp. Date 11/30/2024 ; 17230784, Exp Date 03/31/2025; 17231080, Exp. Date 04/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-553", "16714-554", "16714-555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["a11626b3-d7a9-43b0-85d4-38a582acd661"], "spl_set_id": ["e2511ffe-5821-4f64-a469-f8ef9618b1b5"], "package_ndc": ["16714-553-01", "16714-554-01", "16714-555-01"], "is_original_packager": [true], "upc": ["0316714554013", "0316714553016", "0316714555010"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0096-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-553-01.", "product_quantity": "5232 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #: 17222544, Exp 11/30/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0091-2025", "product_description": "Genuine Joe Antibacterial Lotion Soap , Chloroxylenol 0.1%, 1 GALLON (3.78L), Manufactured in the U.S.A. for S.P. Richards Co., Atlanta, GA 30339", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"status": "Ongoing", "city": "Shirley", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021135"], "brand_name": ["VENOFER"], "generic_name": ["IRON SUCROSE"], "manufacturer_name": ["American Regent, Inc."], "product_ndc": ["0517-2310", "0517-2325", "0517-2340"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRON SUCROSE"], "rxcui": ["1741261", "1741263", "1741267", "1741268", "1741270", "1741271"], "spl_id": ["1cb19ad9-7a23-43bd-ab28-955cd2fa3750"], "spl_set_id": ["626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a"], "package_ndc": ["0517-2325-01", "0517-2325-10", "0517-2340-01", "0517-2340-10", "0517-2340-25", "0517-2310-01", "0517-2310-05"], "is_original_packager": [true], "upc": ["0305172340016", "0305172340252"], "nui": ["M0011718", "N0000177913"], "pharm_class_cs": ["Iron [CS]"], "pharm_class_epc": ["Parenteral Iron Replacement [EPC]"], "unii": ["FZ7NYF5N8L"]}, "product_type": "Drugs", "event_id": "95711", "recalling_firm": "American Regent, Inc.", "address_1": "5 Ramsey Rd", "address_2": "", "postal_code": "11967-4701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0082-2025", "product_description": "Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, American Regent, Inc. Shirley, NY 11967, NDC: 0517-2340-01 (vial), NDC: 0517-2340-10 (10 x 5 mL/vial cartons), NDC: 0517-2340-25 (25 x 5 mL/vial cartons).", "product_quantity": "", "reason_for_recall": "Presence of Particulate Matter: Potential for glass delamination from the vials.", "recall_initiation_date": "20241111", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #s: 4205, Exp 05/31/2026; 24229, 24233, 24239, Exp 07/31/2026.", "more_code_info": ""}]